Key Client Fiduciary Advisors »

Cytosorbents shares owned by Key Client Fiduciary Advisors

Quarter-by-quarter ownership of Cytosorbents (CTSO) shares owned by Key Client Fiduciary Advisors from 13F filings

Historical chart of Key Client Fiduciary Advisors investment in Cytosorbents

Tip: Access up to 7 years of quarterly data

All positions including Cytosorbents held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytosorbents by Key Client Fiduciary Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $52k 35k 1.50
2024-06-30 $24k 35k 0.70
2024-03-31 $33k 35k 0.95
2023-12-31 $13k 12k 1.11
2023-09-30 $24k 13k 1.88
2023-06-30 $43k 12k 3.59
2023-03-31 $40k 12k 3.37
2022-12-31 $19k 12k 1.55
2022-09-30 $16k 12k 1.33
2022-06-30 $26k 12k 2.17

More positions owned by Key Client Fiduciary Advisors

First Tr Exchange-traded Risng Divd Achiv (RDVY)
Apple (AAPL)
Microsoft Corporation (MSFT)
First Tr Exchange Traded Indxx Aerospace (MISL)
First Tr Morningstar Divid L SHS (FDL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Amazon (AMZN)
Oracle Corporation Put Option (ORCL)
Select Sector Spdr Tr Sbi Int-utils (XLU)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange Traded Consumr Staple (FXG)
Annaly Capital Management In Com New (NLY)
Wal-Mart Stores (WMT)

View all positions for Key Client Fiduciary Advisors

Top funds holding Cytosorbents

Avenir Corporation
Skylands Capital
Vanguard Group
Sargent Investment Group
Neuberger Berman Group
CM Management
BlackRock
BlackRock
Geode Capital Management
Atlantic Trust
State Street Corporation
Advisor Group Holdings
Morgan Stanley
AMH Equity
Renaissance Technologies

View all funds holding Cytosorbents